Qiu‐jiang Yan - Concepedia

Author

Qiu‐jiang Yan

Also Known As

Qiu-Jiang Yan, Qiu-jiang Yan, Qiu‐jiang Yan

Publications

Citations

H-Index

Concepts

All Affiliations

Qiu‐jiang Yan is an author at Guangdong Provincial People's Hospital specializing in cell signaling, inflammation, and physiology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	45
2	Cell Biology	2	2	45
3	Immunology	2	2	45
4	Cellular Physiology	1	1	13
5	Pharmacology	1	1	32

Qiu‐jiang Yan

Publications

Citations

H-Index

Page 1

	Year	Citations
Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction Siyu Zeng, Li Yang, Qiu‐jiang Yan, Biomedicine & Pharmacotherapy HypertensionImmunologyCardiovascular PharmacologyRenal InflammationCardiac Regeneration	2018	32
Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway Siyu Zeng, Li Yang, Huiqin Lu, Journal of Cellular and Molecular Medicine	2019	31
Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells Siyu Zeng, Li Yang, Chenliang Hong, Mediators of Inflammation Protective ActionImmunologyAdam17 SirnaAng IiCellular Physiology	2018	13
A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-<i>α</i> Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy Siyu Zeng, Huiqin Lu, Qiu‐jiang Yan, PPAR Research	2018	12
Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2 Siyu Zeng, Qiu‐jiang Yan, Li Yang, Mediators of Inflammation	2020	11

Page 1